<?xml version="1.0" encoding="utf-8"?>
<?taxonomy-generator id="PomdocPro" version="2021.1.1.1" date="2025-04-08 15:32:37"?>
<linkbase 
  xmlns="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"
>
  <roleRef
    roleURI="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
    xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION"
    xlink:type="simple"
  />
  <roleRef
    roleURI="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
    xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#CONSOLIDATEDSTATEMENTSOFINCOMELOSS"
    xlink:type="simple"
  />
  <roleRef
    roleURI="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
    xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS"
    xlink:type="simple"
  />
  <roleRef
    roleURI="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
    xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#CONSOLIDATEDSTATEMENTSOFCASHFLOWS"
    xlink:type="simple"
  />
  <calculationLink xlink:role="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFFINANCIALPOSITION" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IntangibleAssetsOtherThanGoodwill" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IntangibleAssetsOtherThanGoodwill"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_PropertyPlantAndEquipmentIncludingRightouseAssets" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_PropertyPlantAndEquipmentIncludingRightouseAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentAssets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentTradeReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentTradeReceivables"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_OtherAssetsCurrent" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_OtherAssetsCurrent"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashAndCashEquivalents" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashAndCashEquivalents"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Assets" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Assets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Equity" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Equity"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IssuedCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IssuedCapital"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SharePremium" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SharePremium"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_RetainedEarningsExcludingProfitLossForReportingPeriodAndReserveOfExchangeDifferencesOnTranslation" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_RetainedEarningsExcludingProfitLossForReportingPeriodAndReserveOfExchangeDifferencesOnTranslation"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RetainedEarningsProfitLossForReportingPeriod" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RetainedEarningsProfitLossForReportingPeriod"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentDerivativeFinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_ConditionalAdvancesNonCurrentPortion" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_ConditionalAdvancesNonCurrentPortion"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentLeaseLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentGovernmentGrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentGovernmentGrants"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentProvisionsForEmployeeBenefits"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLiabilities"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_ConditionalAdvancesCurrentPortion" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_ConditionalAdvancesCurrentPortion"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentLeaseLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentLeaseLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentProvisions" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentProvisions"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_OtherLiabilitiesCurrent" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_OtherLiabilitiesCurrent"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentDerivativeFinancialLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentDerivativeFinancialLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CurrentPortionOfLongtermBorrowings" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CurrentPortionOfLongtermBorrowings"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_EquityAndLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_EquityAndLiabilities"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_IntangibleAssetsOtherThanGoodwill" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentAssets" order="5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_PropertyPlantAndEquipmentIncludingRightouseAssets" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentAssets" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OtherNoncurrentFinancialAssets" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentAssets" order="7"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentTradeReceivables" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentAssets" order="10"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_OtherAssetsCurrent" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentAssets" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CashAndCashEquivalents" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentAssets" order="12"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentAssets" weight="1.0" priority="1" xlink:from="ifrs-full_Assets" order="8"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentAssets" weight="1.0" priority="1" xlink:from="ifrs-full_Assets" order="13"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_IssuedCapital" weight="1.0" priority="1" xlink:from="ifrs-full_Equity" order="17"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_SharePremium" weight="1.0" priority="1" xlink:from="ifrs-full_Equity" order="18"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_RetainedEarningsExcludingProfitLossForReportingPeriodAndReserveOfExchangeDifferencesOnTranslation" weight="1.0" priority="1" xlink:from="ifrs-full_Equity" order="19"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_RetainedEarningsProfitLossForReportingPeriod" weight="1.0" priority="1" xlink:from="ifrs-full_Equity" order="21"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentDerivativeFinancialLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentLoansReceived" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="26"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_ConditionalAdvancesNonCurrentPortion" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="27"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentLeaseLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="28"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentGovernmentGrants" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="29"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentProvisionsForEmployeeBenefits" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="30"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentPortionOfNoncurrentBondsIssued" weight="1.0" priority="1" xlink:from="ifrs-full_NoncurrentLiabilities" order="24"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_ConditionalAdvancesCurrentPortion" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="36"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentLeaseLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="37"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_TradeAndOtherCurrentPayablesToTradeSuppliers" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="38"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentProvisions" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="39"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_OtherLiabilitiesCurrent" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="40"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentBondsIssuedAndCurrentPortionOfNoncurrentBondsIssued" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="33"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentDerivativeFinancialLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="34"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentPortionOfLongtermBorrowings" weight="1.0" priority="1" xlink:from="ifrs-full_CurrentLiabilities" order="35"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_NoncurrentLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_EquityAndLiabilities" order="31"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CurrentLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_EquityAndLiabilities" order="41"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_Equity" weight="1.0" priority="1" xlink:from="ifrs-full_EquityAndLiabilities" order="22"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_NoncurrentAssetsx" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_NoncurrentAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherNoncurrentFinancialAssetsx" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherNoncurrentFinancialAssets"/>
  </calculationLink>
  <calculationLink xlink:role="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFINCOMELOSS" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_RevenueAndOperatingIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RevenueAndOperatingIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_Revenue" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_Revenue"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OperatingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OperatingExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ResearchAndDevelopmentExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ResearchAndDevelopmentExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_GeneralAndAdministrativeExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_GeneralAndAdministrativeExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_SalesAndMarketingExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_SalesAndMarketingExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLossFromOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLossFromOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_FinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_FinanceIncomeCost"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncomeTaxExpenseContinuingOperations" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncomeTaxExpenseContinuingOperations"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_Revenue" weight="1.0" priority="1" xlink:from="ifrs-full_RevenueAndOperatingIncome" order="4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OtherIncome" weight="1.0" priority="1" xlink:from="ifrs-full_RevenueAndOperatingIncome" order="5"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ResearchAndDevelopmentExpense" weight="1.0" priority="1" xlink:from="ifrs-full_OperatingExpense" order="8"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_GeneralAndAdministrativeExpense" weight="1.0" priority="1" xlink:from="ifrs-full_OperatingExpense" order="9"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_SalesAndMarketingExpense" weight="1.0" priority="1" xlink:from="ifrs-full_OperatingExpense" order="10"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_RevenueAndOperatingIncome" weight="1.0" priority="1" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OperatingExpense" weight="-1.0" priority="1" xlink:from="ifrs-full_ProfitLossFromOperatingActivities" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_FinanceIncomeCost" weight="1.0" priority="1" xlink:from="ifrs-full_ProfitLoss" order="13"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_IncomeTaxExpenseContinuingOperations" weight="-1.0" priority="1" xlink:from="ifrs-full_ProfitLoss" order="14"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProfitLossFromOperatingActivities" weight="1.0" priority="1" xlink:from="ifrs-full_ProfitLoss" order="12"/>
  </calculationLink>
  <calculationLink xlink:role="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFCOMPREHENSIVEINCOMELOSS" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_ComprehensiveIncome" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ComprehensiveIncome"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProfitLoss" weight="1.0" priority="1" xlink:from="ifrs-full_ComprehensiveIncome" order="3"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxGainsLossesOnRemeasurementsOfDefinedBenefitPlans" weight="1.0" priority="1" xlink:from="ifrs-full_ComprehensiveIncome" order="4"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OtherComprehensiveIncomeNetOfTaxExchangeDifferencesOnTranslation" weight="1.0" priority="1" xlink:from="ifrs-full_ComprehensiveIncome" order="5"/>
  </calculationLink>
  <calculationLink xlink:role="http://gensightbiologics.com/xbrl/2023/roles/CONSOLIDATEDSTATEMENTSOFCASHFLOWS" xlink:type="extended">
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProfitLoss" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProfitLoss"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForSharebasedPayments" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForSharebasedPayments"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForFinanceIncomeCost" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForFinanceIncomeCost"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_OtherAdjustmentsForNoncashItems" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_OtherAdjustmentsForNoncashItems"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInWorkingCapital" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInWorkingCapital"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInOperatingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInOperatingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_AcquisitionsReimbursementOfNonCurrentFinancialAssets" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_AcquisitionsReimbursementOfNonCurrentFinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_AcquisitionsReimbursementOfCurrentFinancialAssets" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_AcquisitionsReimbursementOfCurrentFinancialAssets"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_CashFlowsFromUsedInFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_CashFlowsFromUsedInFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_InterestPaidClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_InterestPaidClassifiedAsFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities"/>
    <loc xlink:type="locator" xlink:label="gensightbiologics_RepurchaseOfTreasuryShares" xlink:href="549300NK4AB8OUEX1F54-2024-12-31.xsd#gensightbiologics_RepurchaseOfTreasuryShares"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromExerciseOfWarrants" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromExerciseOfWarrants"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_ProceedsFromIssuingShares" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_ProceedsFromIssuingShares"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_RepaymentsOfBondsNotesAndDebentures" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_RepaymentsOfBondsNotesAndDebentures"/>
    <loc xlink:type="locator" xlink:label="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" xlink:href="https://xbrl.ifrs.org/taxonomy/2022-03-24/full_ifrs/full_ifrs-cor_2022-03-24.xsd#ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProfitLoss" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForDepreciationAndAmortisationExpense" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInEmployeeBenefitLiabilities" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForSharebasedPayments" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForFinanceIncomeCost" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_OtherAdjustmentsForNoncashItems" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" order="6"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInTradeAccountReceivable" weight="-1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInWorkingCapital" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInTradeAccountPayable" weight="-1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInWorkingCapital" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForDecreaseIncreaseInOtherOperatingReceivables" weight="-1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInWorkingCapital" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_AdjustmentsForIncreaseDecreaseInOtherLiabilities" weight="-1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInWorkingCapital" order="11"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CashFlowsFromUsedInOperationsBeforeChangesInWorkingCapital" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="12"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_IncreaseDecreaseInWorkingCapital" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInOperatingActivities" order="12"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_PurchaseOfPropertyPlantAndEquipmentClassifiedAsInvestingActivities" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="17"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_AcquisitionsReimbursementOfNonCurrentFinancialAssets" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="17"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_PurchaseOfIntangibleAssetsClassifiedAsInvestingActivities" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="17"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_AcquisitionsReimbursementOfCurrentFinancialAssets" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInInvestingActivities" order="17"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProceedsFromBorrowingsClassifiedAsFinancingActivities" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_InterestPaidClassifiedAsFinancingActivities" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_PaymentsOfLeaseLiabilitiesClassifiedAsFinancingActivities" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_RepaymentsOfBorrowingsClassifiedAsFinancingActivities" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="gensightbiologics_RepurchaseOfTreasuryShares" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProceedsFromExerciseOfWarrants" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_ProceedsFromIssuingShares" weight="1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_RepaymentsOfBondsNotesAndDebentures" weight="-1.0" priority="1" xlink:from="ifrs-full_CashFlowsFromUsedInFinancingActivities" order="25"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CashFlowsFromUsedInOperatingActivities" weight="1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" order="27"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CashFlowsFromUsedInInvestingActivities" weight="1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" order="27"/>
    <calculationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:to="ifrs-full_CashFlowsFromUsedInFinancingActivities" weight="1.0" priority="1" xlink:from="ifrs-full_IncreaseDecreaseInCashAndCashEquivalentsBeforeEffectOfExchangeRateChanges" order="27"/>
  </calculationLink>
</linkbase>